About
Join us for an insightful session on leveraging insights-driven strategies to optimize the lifecycle management of drugs and medical devices. Discover how Embase, combined with the advanced capabilities of Embase AI, provides comprehensive scientific and clinical intelligence to support decision-making across research, development, regulatory, and post-market activities. Learn how these powerful tools can accelerate innovation, enhance compliance, and enable more informed, data-driven decisions in the rapidly evolving healthcare landscape.

Please note that this seminar will be conducted in Korean.
When
Thursday, August 28, 2025 · 4:00 p.m. Seoul (GMT +9:00)
Presenters
1752718392-074d8a1cd2177b14
Michelle Mohsenin RPh
Product Manager, Embase
Michelle Mohsenin, RPh, is a Product Manager at Elsevier, specializing in Embase for drug safety and pharmacovigilance. As a Subject Matter Expert, she drives innovative solutions to enhance global safety practices. Previously, as Senior Drug Safety Officer at Pfizer, she led the Global Literature Surveillance team, ensuring regulatory compliance and inspection readiness. A licensed pharmacist in New Jersey, Michelle combines industry expertise with a passion for advancing healthcare safety.
1752718470-8593ef8c2b055b13
홍희정 (Alice Hong)
Senior Solution Manager / Korea, Taiwan Corporate
한국과 대만의 기업 고객을 대상으로 엘스비어의 Life Science Solution을 소개하고, 필요한 고객지원을 담당하고 있습니다.
1752718535-622c92eb6ccdba46
김세진 (Sejin Kim)
Customer Consultant / Korea, Taiwan Corporate
엘스비어 Life Science Solution을 이용하고 있는 한국과 대만의 기업 고객을 대상으로 교육 및 지원을 담당하고 있습니다.
Reserve Your Spot
Last Name *
First Name*
Email Address*
Company name*
Department*
Work phone number*
Country*
Contact Permission
We would like to keep you up-to-date with what's happening at Elsevier and tell you about our latest products and other services. We may email you about information we think you'll be interested in, including reminders about upcoming events.
If you do not wish to receive such information please tick the box to opt out of these emails.